عرض بسيط للتسجيلة

المؤلفIannazzo, Daniela
المؤلفEttari, Roberta
المؤلفGiofrè, Salvatore
المؤلفEid, Ali H.
المؤلفBitto, Alessandra
تاريخ الإتاحة2023-08-31T19:19:09Z
تاريخ النشر2020-10-27
اسم المنشورCancers
المعرّفhttp://dx.doi.org/10.3390/cancers12113144
الاقتباسIannazzo, D., Ettari, R., Giofrè, S., Eid, A. H., & Bitto, A. (2020). Recent advances in nanotherapeutics for multiple myeloma. Cancers, 12(11), 3144.
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094900259&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/47150
الملخصAnticancer therapies cannot be included in a one-size-fits-all scenario; it is imperative to adapt therapies to the tumor molecular profile and most importantly to develop target-specific therapeutics. Nanotherapeutics can combine molecular imaging with molecular therapy in order to provide the maximum benefit to patients in terms of disease prevention, identification, and treatment. Nanotechnology applied to therapy provides numerous advantages in diagnostics and in drug delivery, especially for those malignant cells that are diffcult to target or for drugs with poor bioavailability, such as those used for multiple myeloma (MM). This review summarizes the recent advances in the development of nanoparticle-based systems for the treatment of MM, taking into account the methods used for their functionalization, biocompatibility, and anticancer activity.
اللغةen
الناشرMultidisciplinary Digital Publishing Institute (MDPI)
الموضوعLiposome
Multiple myeloma
Nanotechnology
Nanotherapeutics
العنوانRecent advances in nanotherapeutics for multiple myeloma
النوعArticle
رقم العدد11
رقم المجلد12
ESSN2072-6694
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة